Lv1
38 积分 2025-08-15 加入
Aberrant activation of m6A demethylase FTO renders HIF2αlow/- clear cell renal cell carcinoma sensitive to BRD9 inhibitors
5天前
已完结
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
7个月前
已完结
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
7个月前
已完结
The impact of claudin-18.2 expression in patients with advanced gastric cancer treated with nivolumab
7个月前
已完结
皖公网安备34019202002308
